Clinically Significant Gynecomastia in a Newborn with Congenital Heart Disease

Articles in the same Issue

1. TABLE OF CONTENTS
2. Physiological and Pathological Growth Hormone Secretion
3. Choice of Gender in 5α-Reductase Deficiency: A Moving Target
4. Adrenocortical Carcinoma: Prognostic Indices Based on Clinical and Immunohistochemical Markers
5. Androgen Replacement in Adolescents and Young Women with Hypopituitarism
6. Activity of the Growth Hormone/Insulin-like Growth Factor-I Axis in Critically Ill Children
7. Efficacy of Congenital Hypothyroidism Neonatal Screening in Preterms less than 32 Weeks of Gestational Age: More Evidence
8. Active and Total Ghrelin Concentrations in the Newborn
9. Three Novel Mutations in POU1F1 in Israeli Patients with Combined Pituitary Hormone Deficiency
10. Psychological Adjustment of Children with Short Stature: A Comparison of Clinic-Referred Children with Short Stature and Type 1 Diabetes Mellitus
11. 17α-Hydroxylase/17,20-Lyase Deficiency Due to Novel Compound Heterozygote Mutations: Treatment for Tall Stature in a Female with Male Pseudohermaphroditism and Spontaneous Puberty in her Affected Sister
12. A Patient with Klinefelter's syndrome and Thalassemia Intermedia
13. Clinically Significant Gynecomastia in a Newborn with Congenital Heart Disease
14. 18q Deletion Syndrome Associated with Autoimmune Thyroid Disease Presenting as Hyperthyroidism
15. CALENDAR